Question 1

What are the potential benefits of participating in this trial for my child?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy clinical trial (NCT06253221). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should we be aware of with mavacamten?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy clinical trial (NCT06253221). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to other options available for HCM?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy clinical trial (NCT06253221). Contact the study team or your healthcare provider for specific answers.

Question 4

What will the participation process look like, including visits and tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy clinical trial (NCT06253221). Contact the study team or your healthcare provider for specific answers.

Question 5

How long will my child need to participate in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy clinical trial (NCT06253221). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if my child experiences side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy clinical trial (NCT06253221). Contact the study team or your healthcare provider for specific answers.

What this study is about